These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
76 related items for PubMed ID: 20373353
1. Arginine test is not reliable for diagnosing cerebellar multiple system atrophy. Gardner RC, Schmahmann JD. Ann Neurol; 2010 Mar; 67(3):404-8. PubMed ID: 20373353 [Abstract] [Full Text] [Related]
2. Growth hormone response to arginine test distinguishes multiple system atrophy from Parkinson's disease and idiopathic late-onset cerebellar ataxia. Pellecchia MT, Pivonello R, Salvatore E, Faggiano A, Barone P, De Michele G, Lombardi G, Colao A, Filla A. Clin Endocrinol (Oxf); 2005 Apr; 62(4):428-33. PubMed ID: 15807873 [Abstract] [Full Text] [Related]
3. Stimulation of growth hormone release in multiple system atrophy, Parkinson's disease and idiopathic cerebellar ataxia. Pellecchia MT, Salvatore E, Pivonello R, Faggiano A, Barone P, De Michele G, Colao AM, Filla A. Neurol Sci; 2001 Feb; 22(1):79-80. PubMed ID: 11487211 [Abstract] [Full Text] [Related]
4. Sensitivity and specificity of six tests for the diagnosis of adult GH deficiency. Biller BM, Samuels MH, Zagar A, Cook DM, Arafah BM, Bonert V, Stavrou S, Kleinberg DL, Chipman JJ, Hartman ML. J Clin Endocrinol Metab; 2002 May; 87(5):2067-79. PubMed ID: 11994342 [Abstract] [Full Text] [Related]
5. The arginine growth hormone stimulation test in bradykinetic-rigid parkinsonisms. Pellecchia MT, Longo K, Manfredi M, Lucetti C, Cossu G, Petrone A, Marconi R, Sensi M, Epifanio A, Eleopra R, Marchese R, Scaravilli T, Morgante L, Abbruzzese G, Bonuccelli U, Donati E, Pivonello R, Colao A, Barone P. Mov Disord; 2008 Jan 30; 23(2):190-4. PubMed ID: 18044703 [Abstract] [Full Text] [Related]
6. Clonidine GH stimulation test to differentiate MSA from idiopathic late onset cerebellar ataxia: a prospective, controlled study. Bonnard C, Wirth T, Gebus O, Fahrer P, Montaut S, Robelin L, Tuzin N, Tranchant C, Anheim M. J Neurol; 2020 Mar 30; 267(3):855-859. PubMed ID: 32034477 [Abstract] [Full Text] [Related]
7. The comparison of clonidine, arginine and both combined: a growth hormone stimulation test to differentiate multiple system atrophy from idiopathic Parkinson's disease. Zhang K, Zeng Y, Song C, Fu Y, Wan Q. J Neurol; 2010 Sep 30; 257(9):1486-91. PubMed ID: 20405138 [Abstract] [Full Text] [Related]
10. CSF analysis differentiates multiple-system atrophy from idiopathic late-onset cerebellar ataxia. Abdo WF, van de Warrenburg BP, Munneke M, van Geel WJ, Bloem BR, Kremer HP, Verbeek MM. Neurology; 2006 Aug 08; 67(3):474-9. PubMed ID: 16894110 [Abstract] [Full Text] [Related]
11. "Phalanx sign" helps to discriminate MSA-C from idiopathic late onset cerebellar ataxia. Schneider V, Wirth T, Iosif A, Montaut S, Lagha-Boukbiza O, Tranchant C, Anheim M. J Neurol; 2022 Jul 08; 269(7):3900-3903. PubMed ID: 35147729 [Abstract] [Full Text] [Related]
12. Retesting young adults with childhood-onset growth hormone (GH) deficiency with GH-releasing-hormone-plus-arginine test. Aimaretti G, Baffoni C, Bellone S, Di Vito L, Corneli G, Arvat E, Benso L, Camanni F, Ghigo E. J Clin Endocrinol Metab; 2000 Oct 08; 85(10):3693-9. PubMed ID: 11061526 [Abstract] [Full Text] [Related]
13. Impaired chemosensitivity to hypoxia is a marker of multiple system atrophy. Tsuda T, Onodera H, Okabe S, Kikuchi Y, Itoyama Y. Ann Neurol; 2002 Sep 08; 52(3):367-71. PubMed ID: 12205653 [Abstract] [Full Text] [Related]
14. Idiopathic cerebellar ataxia (IDCA): Diagnostic criteria and clinical analyses of 63 Japanese patients. Yoshida K, Kuwabara S, Nakamura K, Abe R, Matsushima A, Beppu M, Yamanaka Y, Takahashi Y, Sasaki H, Mizusawa H, Research Group on Ataxic Disorders. J Neurol Sci; 2018 Jan 15; 384():30-35. PubMed ID: 29249373 [Abstract] [Full Text] [Related]
15. MRI-based volumetric differentiation of sporadic cerebellar ataxia. Burk K, Globas C, Wahl T, Bühring U, Dietz K, Zuhlke C, Luft A, Schulz JB, Voigt K, Dichgans J. Brain; 2004 Jan 15; 127(Pt 1):175-81. PubMed ID: 14570820 [Abstract] [Full Text] [Related]
16. The glucagon test in the diagnosis of growth hormone deficiency in children with short stature younger than 6 years. Secco A, di Iorgi N, Napoli F, Calandra E, Ghezzi M, Frassinetti C, Parodi S, Casini MR, Lorini R, Loche S, Maghnie M. J Clin Endocrinol Metab; 2009 Nov 15; 94(11):4251-7. PubMed ID: 19837934 [Abstract] [Full Text] [Related]
17. GHRH plus arginine in the diagnosis of acquired GH deficiency of childhood-onset. Maghnie M, Cavigioli F, Tinelli C, Autelli M, Aricò M, Aimaretti G, Ghigo E. J Clin Endocrinol Metab; 2002 Jun 15; 87(6):2740-4. PubMed ID: 12050243 [Abstract] [Full Text] [Related]
18. The usefulness of the combined growth hormone (GH)-releasing hormone and arginine stimulation test in the diagnosis of radiation-induced GH deficiency is dependent on the post-irradiation time interval. Darzy KH, Aimaretti G, Wieringa G, Gattamaneni HR, Ghigo E, Shalet SM. J Clin Endocrinol Metab; 2003 Jan 15; 88(1):95-102. PubMed ID: 12519836 [Abstract] [Full Text] [Related]
19. The growth hormone (GH) response to the arginine plus GH-releasing hormone test is correlated to the severity of lipid profile abnormalities in adult patients with GH deficiency. Colao A, Cerbone G, Pivonello R, Aimaretti G, Loche S, Di Somma C, Faggiano A, Corneli G, Ghigo E, Lombardi G. J Clin Endocrinol Metab; 1999 Apr 15; 84(4):1277-82. PubMed ID: 10199767 [Abstract] [Full Text] [Related]
20. Relationship between the morphological evaluation of the pituitary and the growth hormone (GH) response to GH-releasing hormone Plus arginine in children and adults with congenital hypopituitarism. Maghnie M, Salati B, Bianchi S, Rallo M, Tinelli C, Autelli M, Aimaretti G, Ghigo E. J Clin Endocrinol Metab; 2001 Apr 15; 86(4):1574-9. PubMed ID: 11297586 [Abstract] [Full Text] [Related] Page: [Next] [New Search]